Revel Pharmaceuticals

Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological, age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically positioned to develop therapeutics across multiple indications.

Website

http://revelpharmaceuticals.com

External link for Revel Pharmaceuticals

Industry

Biotechnology Research

Company size

2-10 employees

Headquarters

San Francisco, CA

Type

Privately Held

Founded

2019